Erlotinib as Frontline Treatment for Elderly Patients With Advanced Non-Small-Cell Lung Cancer (NSCLC) and Non-Squamous Histology - Results of a Galician Lung Cancer Group (GGCP044/09 Study) Grupo Galego De Cancro De Pulmon (GGCP)

被引：0
|
作者：
Firvidal, J. L. [1 ]
Vazquez, S. [2 ]
Casal, J. [3 ]
Fernandez, A. [1 ]
Varela, S. [2 ]
Villanueva, M. J. [3 ]
Perez, E. [1 ]
Campos, B. [2 ]
Salgado, M. [1 ]
Mel, J. R. [2 ]
机构：
[1] Complexo Hosp Ourense, Orense, Spain
[2] Hosp Lucus Augusti, Lugo, Spain
[3] Univ Vigo, Complexo Hosp, Vigo 36310, Spain
来源：
EUROPEAN JOURNAL OF CANCER | 2011年 / 47卷
关键词：
D O I：
10.1016/S0959-8049(11)72400-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S619 / S619
页数：1
相关论文
共 50 条
  • [21] The global TRUST study of erlotinib in advanced non-small-cell lung cancer (NSCLC)
    Groen, H.
    Arrieta, O. G.
    Riska, H.
    Horwood, K.
    Mali, P.
    Reck, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [22] FIRST-LINE ERLOTINIB IN ELDERLY PATIENTS (PTS) WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Merimsky, O.
    Cheng, A. C.
    Reck, M.
    Au, S. K.
    von Pawel, J.
    ANNALS OF ONCOLOGY, 2008, 19 : 101 - 102
  • [23] Biweekly docetaxel as second-line chemotherapy of patients with advanced non-small cell lung cancer:: a phase II study of the Galician Lung Cancer Group (GGCP 006-00)
    Vázquez, S
    Grande, C
    Amenedo, M
    Fírvida, JL
    Lázaro, M
    Alonso, G
    Curiel, T
    Huidobro, G
    Mel, JR
    Ramos, M
    ANTI-CANCER DRUGS, 2004, 15 (05) : 489 - 494
  • [24] Phase II Studies of Nivolumab in Patients with Advanced Squamous (SQ) or Non-Squamous (NSQ) Non-Small-Cell Lung Cancer (NSCLC)
    Nakagawa, Kazuhiko u
    Nishio, Makoto
    Hida, Toyoaki
    Sakai, Hiroshi
    Nogami, Naoyuki
    Atagi, Shinji
    Takahashi, Toshiaki
    Nokihara, Hiroshi
    Saka, Hideo
    Takenoyama, Mitsuhiro
    Fujita, Shiro
    Tanaka, Hiroshi
    Takeda, Koji
    Satouchi, Miyako
    Isobe, Hiroshi
    Maemondo, Makoto
    Goto, Koichi
    Hirashima, Tomonori
    Minato, Koichi
    Tamura, Tomohide
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S270 - S271
  • [25] CONTINUATION MAINTENANCE FOR ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Okamoto, Isamu
    ANNALS OF ONCOLOGY, 2014, 25
  • [26] CLINICAL INVESTIGATION OF CISPLATINE/PEMETREXED IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER
    Watanabe, K.
    Okuma, Y.
    Nakahara, Y.
    Yomota, M.
    Takagi, Y.
    Hosomi, Y.
    Okamura, T.
    ANNALS OF ONCOLOGY, 2013, 24 : 86 - 86
  • [27] Efficacy and safety of bevacizumab in the treatment of advanced, non-squamous non-small cell lung cancer (NSCLC)
    Tassinari, D.
    Drudi, F.
    Carloni, F.
    Nicoletti, S.
    Possenti, C.
    Santelmo, C.
    Lazzari, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [28] Pemetrexed versus vinorelbine treatment of advanced non-squamous non-small cell lung cancer in elderly patients
    Chen, Yongshun
    Wen, Qinglian
    Liu, Hao
    Ao, Rui
    Wu, Xiaoyuan
    Guo, Leiming
    Wang, Wen
    He, Chunyu
    Wang, Jianhua
    MOLECULAR AND CLINICAL ONCOLOGY, 2013, 1 (03) : 553 - 557
  • [29] Oral vinorelbine (NVBO) and gemcitabine (GEM) in elderly patients with advanced non-small-cell lung cancer (NSCLC): A phase II study conducted by the Galician Lung Cancer Group (GLCG)
    Firvida, J. L.
    Vazquez, S.
    Grande, C.
    Leon, L.
    Salgado, M.
    Campos, B.
    Lazaro, M.
    Lopez, R.
    Perez, E.
    Casal, J.
    Mel, J. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] ORAL VINORELBINE (NVBO) AND GEMCITABINE (GEM) IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC): A PHASE II STUDY CONDUCTED BY THE GALICIAN LUNG CANCER GROUP (GLCG)
    Firvida, J. L.
    Vazquez, S.
    Lazaro, M.
    Leon, L.
    Salgado, M.
    Campos, B.
    Fernandez, A.
    Casal, J.
    Gayo, J.
    Mel, J. R.
    ANNALS OF ONCOLOGY, 2008, 19 : 97 - 97
12345